His broad clinical experience has been well employed on trials across multiple disciplines including: pain/therapeutics, anesthesiology, immunology, lipid/metabolism, viral hepatitis, Alzheimer’s disease, and depression. Sabet joined ICON as a Sub-Investigator in September of 2015.
Ultimately, he settled in Salt Lake City and after more than ten years of practicing and teaching clinical medicine, he found his way back to research.ĭr.
He spent a year working as a consultant physician in New Zealand after which he returned to work as an Internal Medicine hospitalist in several areas across the western United States.
#Care now lenexa series#
Sabet embarked on a series of travel medicine assignments. He went on to become Chief Resident in Internal Medicine at Maricopa Medical Center and soon thereafter obtained his board certifications in both Internal Medicine and Pediatrics.įollowing residency Dr. There he completed a dual residency in Internal Medicine and Pediatrics from Maricopa Medical Center in affiliation with Phoenix Children’s Hospital.
Sabet returned to the United States for continued training in Phoenix, Arizona. He continued his education in Puerto Rico, and ultimately obtained his Medical Degree from Ponce School of Medicine.Īfter medical school, Dr. He completed his first two years of medical school at the Universidad Autonoma de Guadalajara where he acquired a solid foundation in clinical medicine and fluency in Spanish. With this, he was the principal or sub-investigator for numerous trials examining the ADME (Absorption, Distribution, Metabolism and Excretion) and Pharmacokinetics of C 14 -labelled compounds in healthy/normal and Oncology patient populations. He also certified and became licensed as an Authorized User of Radioactivity for the State of Washington. As Principal Investigator, his studies included First-In-Human trials as well as Oncology, Dermatology, Chronic Hepatitis C and Vaccine trials. Searle returned to early-phase research at Comprehensive Clinical Development in Tacoma, Washington. Study areas included Diabetes, Lupus, Alzheimer’s disease, Rheumatoid Arthritis, Multiple Sclerosis, Bipolar disorder and Healthy/Normal populations.Īfter a short time back in clinical medicine, Dr. Searle helped it grow to be one of the premiere early-phase, patient-population sites in the Southwest. He was Medical Director and Principal Investigator, and also on the company’s Board of Directors, for the first two years of the company’s existence and Dr. Searle began pharmaceutical research at Dedicated Phase One in Phoenix. Searle then went to Phoenix, Arizona and completed his residency in Family Medicine at Banner Good Samaritan Hospital.ĭr. While completing his Medical Doctor Degree, he also participated in research with the orthopedic department examining the calcification processes of synovial and connective tissues. His medical training was at the University of Texas Health Science Center in San Antonio, TX. Searle attended Brigham Young University, majoring in Psychology with a pre-medicine emphasis.
0 kommentar(er)
